About the Authors
- Olivia Keiser
-
Affiliation Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
- Catherine Orrell
-
Affiliation The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, Western Cape, South Africa
- Matthias Egger
-
*To whom correspondence should be addressed. E-mail: egger@ispm.unibe.ch
Affiliations Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland , Department of Social Medicine, University of Bristol, Bristol, United Kingdom
- Robin Wood
-
Affiliation The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, Western Cape, South Africa
- Martin W. G Brinkhof
-
Affiliation Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
- Hansjakob Furrer
-
Affiliation Division of Infectious Diseases, University Hospital, University of Bern, Bern, Switzerland
- Gilles van Cutsem
-
Affiliation Khayelitsha Site B, Médecins Sans Frontières, Cape Town, Western Cape, South Africa
- Bruno Ledergerber
-
Affiliation Division of Infectious Diseases, University Hospital Zürich, Zürich, Switzerland
- Andrew Boulle
-
Affiliation School of Public Health and Family Medicine, University of Cape Town, South Africa
- for the Swiss HIV Cohort Study (SHCS) and the International Epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA-SA)
Competing Interests
HF has participated in advisory boards of GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMS), Gilead, Merck Sharp & Dohme-Chibret (MSD) and Boehringer-Ingelheim. The institution of HF has received unrestricted educational grants from Abbott, GSK, BMS, Roche, Gilead, MSD, Boehringer-Ingelheim, and Essex. The other authors declare that they have no competing interests.
Author Contributions
OK, ME, and AB designed the study. CO, RW, HF, GvC, and AB collected data for the study and enrolled patients. OK wrote the first draft of the paper, which was subsequently revised by CO and ME. All authors contributed to the final version of the paper. CO collected and entered all the data from the South African Gugulethu site. ME, MWGB, BL, and AB advised on the statistical analyses, which were done by OK. GvC represents the Khayelitsha cohort collaboration team, which includes staff from Médecins Sans Frontières, the Infectious Disease Epidemiology Unit, and the Provincial Government of the Western Cape.